Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care IT services specialist Catamaran has earned a coveted five-star ranking.
With that in mind, let's take a closer look at Catamaran and see what CAPS investors are saying about the stock right now.
Lisle, Ill. (1993)
Chairman/CEO Mark Thierer (since 2012)
CFO Jeffrey Park (since 2012)
Return on Equity (average, past 3 years)
$311.4 million / $1.1 billion
Caremark Pharmacy Services
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 392 members who have rated Catamaran believe the stock will outperform the S&P 500 going forward.
Buy-out Bait! An innovative company with a lot of management hustle and lots of little deals with big companies. This is an area that can't not grow, not with the aching need to rationalize health care records and management. Demographics, debt, and management urgency are all behind the [Catamaran].
While you can certainly make huge gains in health care stocks, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article Why Catamaran Is Poised to Bounce Back originally appeared on Fool.com.
Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends Catamaran and Express Scripts. The Motley Fool owns shares of Catamaran and Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.